Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Gynecologic 1 Genitourinary 1

Conditions

Lymphoma, Follicular 1 Cognitive Dysfunction 1 Alzheimer Disease 1

Interventions

Cyclophosphamide 170 Rituximab 143 Specimen Handling 82 venetoclax 79 fludarabine 78 Vincristine 69 obinutuzumab 67 Doxorubicin 66 Prednisone 65 Biopsy 64 Magnetic Resonance Spectroscopy 62 zanubrutinib 52 Lenalidomide 52 Dexamethasone 49 Methotrexate 43 Cytarabine 43 blinatumomab 40 acalabrutinib 37 Immunotherapy, Adoptive 37 Bendamustine Hydrochloride 37 Etoposide 32 fludarabine phosphate 31 ibrutinib 28 glofitamab 28 polatuzumab vedotin 26 pirtobrutinib 24 orelabrutinib 24 Gemcitabine 23 Injections 21 Mercaptopurine 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × fasudil × Lymphoid × Clear all

NCT06362707 2026-05-04

FEAD

Helse Stavanger HF

Phase 2 Recruiting

Alzheimer Disease, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡